60 Participants Needed

Self-Directed Hand Therapy for Stroke Recovery

(SAGEH Trial)

SR
AG
Overseen ByArnold Gomez, Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores the effects of self-administered hand therapy for individuals recovering from a stroke. It aims to determine if regular exercises and games at home, known as Self-Administered Gaming and Exercise at Home (SAGEH), can improve hand and arm function more effectively than usual care alone. Participants will either engage in these self-guided sessions with occasional telemedicine check-ins or follow the standard care routine. Ideal candidates are those who have recently experienced a stroke, have impaired hand or arm function, and are comfortable with remote check-ins. As an unphased trial, this study provides a unique opportunity to contribute to innovative stroke recovery research.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that self-administered hand therapy is safe for stroke recovery?

Research has shown that self-guided gaming and exercise can be safe for people recovering from a stroke. In one study, participants who used gaming technology for arm recovery after a stroke exercised more, doubling their exercise time and performing eight times more repetitions compared to traditional methods. This suggests that the treatment is generally well-tolerated.

Additionally, studies have examined the use of digital technology at home, such as telerehabilitation and gamification (adding game-like features), in stroke recovery. These methods help individuals safely and effectively improve arm movement at home.

While specific details on side effects aren't provided, these findings suggest that self-directed gaming and exercise treatments are safe and can be effectively included in stroke recovery plans.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for stroke recovery because they offer a self-directed approach that can be done at home, making rehabilitation more accessible. Unlike traditional therapies that often require in-person sessions with a therapist, these treatments involve self-administered exercises and gaming through a tablet interface, allowing participants to engage in rehabilitation on their own schedule. The use of a knob-like computer interface for game-like tasks is a novel delivery method, encouraging active participation and potentially improving motivation and adherence. This self-directed method is complemented by brief telemedicine check-ins with a licensed occupational therapist, ensuring safety and guidance without the need for constant supervision.

What evidence suggests that this trial's treatments could be effective for stroke recovery?

This trial will evaluate the effectiveness of self-directed gaming and exercise at home through the Self-Administered Gaming and Exercise at Home (SAGEH) program for stroke recovery. Participants in Treatment Arm G1 will engage in self-administered sessions focusing on stretches, warm-up, and strengthening exercises to improve hand function. Meanwhile, participants in Treatment Arm G2 will use a knob-like computer interface connected to a tablet for game-like tasks to enhance hand dexterity and coordination. Studies have shown that such self-directed activities can double exercise time and increase repetitions by eight times for stroke patients, improving hand function through frequent and consistent practice. One study found that using interactive gaming technology for self-directed rehabilitation improved arm use in stroke survivors. These findings suggest that adding self-administered hand therapy to standard care could enhance recovery.23678

Who Is on the Research Team?

SR

Steven R Zeiler, MD, PhD

Principal Investigator

Johns Hopkins University

Are You a Good Fit for This Trial?

The SAGEH trial is for adults over 21 who've had a stroke within the last 6 weeks, resulting in hand weakness but can still do some exercises. They must be able to communicate in English and give consent. People with severe arm impairment, recent Botox treatments, other major health issues affecting motor function or cognitive impairments are not eligible.

Inclusion Criteria

Admitted to the Johns Hopkins Hospital (JHH) inpatient stroke service
Proficient in speaking and reading English
You meet the JSTTEP criteria and are part of the JSTTEP program.
See 6 more

Exclusion Criteria

My arm is severely impaired and cannot function well.
I have received a Botox injection in my arm after having a stroke.
I cannot sit and do hand exercises for 20 minutes.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Baseline Assessment

Participants undergo baseline gaming, functional, and cognitive assessments while still inpatients

1 week
1 visit (in-person)

Treatment

Participants receive self-administered therapy sessions with telemedicine check-ins over 3 weeks

3 weeks
2 telemedicine check-ins per week

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months
Regular follow-up assessments

What Are the Treatments Tested in This Trial?

Interventions

  • Self-Administered Gaming and Exercise at Home (SAGEH)
Trial Overview This study tests if doing extra hand therapy at home after a stroke helps improve manual functions more than just standard care. Participants will either follow their usual outpatient therapy or add self-directed exercises using a device called NoNo to see which method leads to better recovery.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Treatment Arm G2Experimental Treatment1 Intervention
Group II: Treatment Arm G1Active Control1 Intervention
Group III: Control Group (CG)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

Sheikh Khalifa Stroke Institute

Collaborator

Trials
3
Recruited
220+

Published Research Related to This Trial

In a study involving 30 inpatient stroke survivors, the use of an adapted upper limb exergaming device significantly increased exercise duration to an average of 51 minutes per day, doubling the amount of therapy compared to conventional supervised care.
Participants using the exergaming device performed an average of 104 upper limb repetitions daily, which is eight times more than the 15 repetitions achieved through standard therapy, demonstrating the device's potential to enhance rehabilitation outcomes without additional supervision.
Self-Directed Exergaming for Stroke Upper Limb Impairment Increases Exercise Dose Compared to Standard Care.Broderick, M., Almedom, L., Burdet, E., et al.[2022]
The LSVT BIG program showed promising results in improving upper extremity motor function and self-reported occupational performance in a 52-year-old woman with mild to moderate hemiparesis two years post-stroke.
This study suggests that the LSVT BIG program can be adapted for stroke rehabilitation, and future research will involve a larger, more diverse group to further assess its effectiveness.
Lee Silverman Voice Treatment BIG® for a Person With Stroke.Proffitt, RM., Henderson, W., Scholl, S., et al.[2019]
The Home Arm Movement Stroke Training Environment (HAMSTER) program, which uses Kinect games, was found to be usable and engaging for individuals with stroke, highlighting its potential as a motivational home therapy intervention.
A one-month trial of HAMSTER by a participant with chronic stroke showed good compliance and improvements in clinical outcomes, suggesting that this gaming approach could effectively enhance upper extremity function and support recovery at home.
Usability evaluation of a kinematics focused Kinect therapy program for individuals with stroke.Brokaw, EB., Eckel, E., Brewer, BR.[2022]

Citations

Self-Directed Exergaming for Stroke Upper Limb ...Self-directed adapted exergaming enabled participants in our stroke inpatient cohort to increase exercise duration 2-fold, and repetitions 8-fold, compared to ...
Self-Directed Hand Therapy for Stroke Recovery (SAGEH Trial)This study aims at comparing manual function outcomes between the standard of care and additional self-administered hand therapy after stroke.
Self-directed Adapted Gaming Exercises for stroke survivorsThis study was a pilot RCT, testing the use of an interactive gaming technology (GripAble) for self-directed arm rehabilitation after stroke.
Rehabilitation via HOMe Based gaming exercise for the ...This study aims to determine the safety, feasibility and acceptability of the Neurofenix platform for home-based rehabilitation of the upper-limb poststroke. A ...
Self-Directed Exergaming for Stroke Upper Limb ...Here we quantify the exercise dose achieved by inpatient stroke survivors using an adapted upper limb (UL) exercise gaming (exergaming) device ...
Self-Administered Gaming and Exercise at Home (SAGEH)This study aims at comparing manual function outcomes between the standard of care and additional self-administered hand therapy after stroke.
The use of home-based digital technology to support post- ...The digital technologies used in post-stroke upper limb rehabilitation were multimodal, and system-based comprising telerehabilitation, gamification, virtual ...
Home-Based Virtual Reality Exergame Program after Stroke ...This study will aim to determine the effectiveness of home-based VRET for patients with stroke who have been discharged from the hospital.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security